Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 856.20
-38.40 (-4.29%)
Aug 14, 2025, 1:28 PM IDT
Epitomee Medical Company Description
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide.
Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction.
Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule.
The company was incorporated in 2005 and is based in Caesarea, Israel.
Epitomee Medical Ltd
| Country | Israel |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Radan Hashimshony |
Contact Details
Address: 19 Tarshish Caesarea, 3088900 Israel | |
| Phone | 972 7 225 05992 |
| Website | epitomeemedical.com |
Stock Details
| Ticker Symbol | EPIT |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011825911 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Argil Cohen | Chief Executive Officer of Research & Development |
| Dr. Radan Hashimshony Ph.D. | Chief Executive Officer and General Secretary |
| Dr. Shimon Eckhouse Ph.D. | Co-Founder and Chairman of the Board |
| Gal Aharonowitz | Chief Operating Officer |
| Dr. Yael Kidan | Vice President of Clinical Affairs |
| Maya Gabrieli | Vice President of Finance |
| Alon Heth | Vice President of Sales and Marketing |
| Dr. Ruthie Amir M.D. | Chief Medical and Regulatory Officer |